Treatment options for primary biliary cholangitis are expanding, although some questions remain. The condition's incidence and prevalence are growing, making prompt diagnosis and management key to quality of life. The development of new treatments, including certain liver drugs and therapies, may offer hope for patients, but the regulatory process for some of these options has been lengthy.